Nippon Chemiphar CoTSE:4539 +1.38%59 Days Payable is 31.12 as of Mar. 2026, which is 6% below its 10-year median of 33.28. GuruFocus rates TSE:4539 with a GF Score™ of 59/100 and a GF Value™ of 円1,705.64 (Fairly Valued). The stock has 9 warning signs investors should review. Among 927 Drug Manufacturers companies, Nippon Chemiphar Co ranks worse than 87.06% on this metric.
The historical rank and industry rank for Nippon Chemiphar Co's Days Payable or its related term are showing as below:
TSE:4539'
s Days Payable Range Over the Past 10 Years
Min: 17.13 Med: 33.28 Max: 36.62
Current: 33.36
During the past 13 years, Nippon Chemiphar Co's highest Days Payable was 36.62. The lowest was 17.13. And the median was 33.28.
TSE:4539's Days Payable is ranked worse than 87.06% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs TSE:4539: 33.36
Nippon Chemiphar Co's Days Payable
declined
from Mar. 2025 (32.33) to Mar. 2026 (31.12).
It may suggest that Nippon Chemiphar Coaccelerated paying its suppliers.
Nippon Chemiphar Co Days Payable Related Terms
Nippon Chemiphar Co Days Payable Historical Data
* Premium members only.
The historical data trend for Nippon Chemiphar Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Chemiphar Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nippon Chemiphar Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nippon Chemiphar Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Nippon Chemiphar Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Nippon Chemiphar Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nippon Chemiphar Co (TSE:4539) has a Days Payable of 31.12 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nippon Chemiphar Co and its competitors. This is near median its historical median of 33.28. Over the past decade, Nippon Chemiphar Co's Days Payable has ranged from 17.13 to 36.62. According to the industry distribution chart, Nippon Chemiphar Co ranks #807 out of 927 companies in the Drug Manufacturers industry, placing it in the top 87.1%.
Is Nippon Chemiphar Co's Days Payable too high?
Nippon Chemiphar Co's current Days Payable of 31.12 is near median its 10-year median of 33.28. Over the past 10 years, this metric has ranged from a low of 17.13 to a high of 36.62. The Drug Manufacturers industry median Days Payable is 90.38. Nippon Chemiphar Co's value of 31.12 is 65.6% below this industry median. Based on the distribution chart, Nippon Chemiphar Co ranks #807 out of 927 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Nippon Chemiphar Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nippon Chemiphar Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Nippon Chemiphar Co ranks #807 out of 927 companies for Days Payable. This places Nippon Chemiphar Co in the lower half of its industry. The industry median Days Payable is 90.38. Nippon Chemiphar Co's value of 31.12 is 65.6% below this benchmark. Historically, Nippon Chemiphar Co's own Days Payable has ranged from 17.13 to 36.62 over the past decade. While the company's 10-year median is 33.28 vs. the industry median of 90.38, Nippon Chemiphar Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nippon Chemiphar Co's current Days Payable of 31.12 is 65.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nippon Chemiphar Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nippon Chemiphar Co's current Days Payable is 31.12, which is near median its own 10-year median of 33.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Chemiphar Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Chemiphar Co (TSE:4539) is currently considered Fairly Valued. The stock's GF Value™ is 円1,705.64, compared to a current price of 円1,692.00 — trading 0.8% below its estimated fair value. The current Days Payable is 31.12, which is near median its 10-year median of 33.28 and 65.6% below the Drug Manufacturers industry median of 90.38. Nippon Chemiphar Co's overall GF Score™ is 59/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nippon Chemiphar Co (TSE:4539), the current Days Payable is 31.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nippon Chemiphar Co (TSE:4539) Overvalued in 2026?
Based on GuruFocus' analysis, Nippon Chemiphar Co stock appears to be undervalued.
The current stock price of 円1,692.00 is trading 0.8% below its estimated GF Value™ of 円1,705.64.
GuruFocus considers Nippon Chemiphar Co to be Fairly Valued.
Key valuation signals for TSE:4539:
Days Payable: 31.12 (near median its 10-year median of 33.28)
GF Value™: 円1,705.64 vs. price of 円1,692.00 (0.8% below fair value)
Industry Position: 65.6% below the Drug Manufacturers median (#807 of 927)
No single metric tells the full story. See the TSE:4539 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nippon Chemiphar Co Ltd produces and sells medicines for medical use. The company also produces medical, health and cosmetics products. Nippon Chemiphar sterilizes medical instruments for hospitals and operates nursing home for elderly.
59GF Score
Get the complete analysis for TSE:4539
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4539 has been successfully added to your 
